Abstract
The crystalline lens lens thickness playing an essential role in maintaining normal visual function, but little attention is paid to the lens thickness. The purpose of this study is to document the normative values of lens thickness (LT) in healthy subjects of Southern China and to evaluate its associated factors. This was a prospective, clinic-based, observational, cross-sectional study. A total of 526 eyes from 263 healthy subjects aged between 5-84 years (mean age, 38.48 ± 22.04 years) were included in the study. All subjects underwent detailed ophthalmic examination, including the measurement of ocular biometric parameters by LenStar LS900. The study focused on LT and its association with general and ocular factors. The generalized estimation equation (GEE) model was used for statistical analysis. The Mean LT was 4.01 ± 0.57 mm(95% CI, 3.97 - 4.06; median, 3.94 mm; range, 3.10 - 5.36). In a univariate regression analysis, the LT was associated significantly age, body weight, body height, body mass index (BMI), systolic pressure, diastolic pressure, spherical equivalent (SE), intraocular pressure (IOP), anterior chamber depth (ACD) and axial length (AL) (all P<0.05). After adjusting the general parameters and ocular parameters, LT was associated significantly with age (β, 0.0151; 95% CI, 0.0116 - 0.0186; P<0.001), gender (β, 0.1233; 95% CI, 0.0553 - 0.1913; P<0.001) and ACD (β, -0.5815; 95% CI, -0.8059 - -0.3571; P<0.001) using the multivariate regression model. The LT was associated with older age, female gender, and shallower ACD in healthy subjects from Southern China. The data may help understand ocular diseases concerning lens thickness.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was registered on the Chinese Clinical Trial Registry (identifier: ChiCTR1900024921) and approved by the Institutional Review Board of Foshan Second Hospital.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Data Availability
All relevant data are within the manuscript and its Supporting Information files
Abbreviations
- ACD
- anterior chamber depth
- AL
- axial length
- BCVA
- best-corrected visual acuity
- BMI
- body mass index
- CCT
- central corneal thickness
- CI
- confidence intervals
- CMT
- central macular thickness
- GEE
- generalized estimation equation
- IOP
- intraocular pressure
- LT
- lens thickness
- SD
- standard deviation
- SE
- spherical equivalent.
